Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$26.79

-0.31 (-1.14%)

10:50
11/28/16
11/28
10:50
11/28/16
10:50

AstraZeneca attracts a bullish option play

AstraZeneca attracts a bullish option play. A Jul 30 - 32.5 call stupid spread is bought for $2.25, 10K, untied. The investor is buying both strikes, to open. With the stock down 30c to $26.80, the new positoin is targeting a 20.3% rally, or better, through the July 2017 expiration. The 52-week high of $34.77 dates back to 12/1/15. The stock touched 52-week lows of $26.37 last week.

  • 29

    Nov

  • 03

    Dec

  • 16

    Feb

AZN AstraZeneca
$26.79

-0.31 (-1.14%)

10/20/16
JANY
10/20/16
NO CHANGE
Target $1.5
JANY
Neutral
Cerulean cash infusion gives chance to execute on programs, says Janney Capital
Janney Capital analyst Debjit Chattopadhyay said Cerulean's (CERU) collaboration with Novartis (NVS), which comes with a "modest" $5M upfront payment, and its $20M ATM facility with Aspire Capital, while "not ideal," gives management a chance to execute on three of its ongoing programs, the most important of which is the dose escalation study with Olaparib with partner AstraZeneca (AZN) that should have preliminary data in 2Q17. The analyst raised his fair value estimate on Cerulean to $1.50 from $1.00 and keeps a Neutral rating on the stock.
10/26/16
PIPR
10/26/16
NO CHANGE
PIPR
Neutral
Piper still uncertain on Clovis position after AstraZeneca data
AstraZeneca's (AZN) Phase III study of Lynparza in ovarian cancer "substantially improved" progression-free survival over what was seen in study 19, suggesting a profile at least similar to TESARO's (TSRO) niraparib, Piper Jaffray analyst Steven Breazzano tells investors in a research note. The new data confirm that the various PARP inhibitors are more similar than different, which bodes well for Clovis Oncology's (CLVS) own maintenance study, the analyst contends. Breazzano, however, remains the sidelines with respect to Clovis shares given the "increasingly competitive dynamic" in ovarian cancer and uncertainty in the company's position in the important maintenance setting. The analyst keeps a Neutral rating on Clovis.
11/09/16
SBSH
11/09/16
NO CHANGE
SBSH
Citi sees Healthcare 'relief rally' after Trump win
Citi analyst Andrew Baum expects a "'relief rally" to drive near-term sector outperformance for names in the Healthcare space given the "inability of the Democrats to attain the Presidency, the House or Congress." Longer term, however, the analyst still sees "significant continued legislative risk" for pharma reimbursement. Baum prefers GlaxoSmithKline (GSK), AstraZeneca (AZN), Shire (SHPG) and Roche (RHHBY) among European majors and Bristol-Myers (BMY) and Eli Lilly (LLY) in the U.S.
11/28/16
SBSH
11/28/16
DOWNGRADE
Target $60
SBSH
Neutral
Citi analyst 'perturbed,' downgrades AbbVie to Neutral
Citi analyst Andrew Baum earlier today downgraded AbbVie (ABBV) to Neutral from Buy and lowered his price target for the shares to $60 from $65. The biopharmaceutical company is trading down 2%, or 99c, to $59.52. The risk to post 2017 consensus estimates for Humira has "increased on almost all fronts," Baum tells investors in a research note. The analyst sees increased patent risk and competition from biosimilar Enbrel in Europe. He also believes AstraZeneca (AZN) and Acerta's acalabrutinib "looks like a better mousetrap" than AbbVie's Imbruvica. Baum is also "perturbed" by AbbVie management's recent "rich" acquisition of Stemcentrx. He prefers shares of Eli Lilly (LLY) and Bristol-Myers (BMY) to AbbVie.

TODAY'S FREE FLY STORIES

SBBP

Strongbridge Biopharma

$8.70

0.25 (2.96%)

16:27
01/23/18
01/23
16:27
01/23/18
16:27
Syndicate
Strongbridge Biopharma files to sell 5M shares of common stock »

JMP Securities is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$120.00

0.56 (0.47%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Technical Analysis
Technical Take: Texas Instruments drops sharply after results »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Hot Stocks
Breaking Hot Stocks news story on Capital One »

Capital One reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

JAX

J. Alexander's

$10.20

-0.3 (-2.86%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Hot Stocks
J. Alexander's major holders support 99 Restaurants acquisition »

Substantial holders of J.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

TK

Teekay Corp.

$10.74

0.05 (0.47%)

16:25
01/23/18
01/23
16:25
01/23/18
16:25
Syndicate
Teekay Corp. 10M share Spot Secondary; price range $9.75-$10.00 »

Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$105.71

0.22 (0.21%)

16:25
01/23/18
01/23
16:25
01/23/18
16:25
Hot Stocks
Breaking Hot Stocks news story on Capital One »

Capital One reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ROL

Rollins

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Hot Stocks
Rollins raises dividend 21.7% to 14c »

Rollins approved a 21.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Hot Stocks
Capital One reports Q4 net interest margin 7.03%, down 5 bps »

Reports Efficiency ratio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Earnings
Capital One reports Q4 adjusted EPS $1.62, consensus $1.88 »

Reports Q4 revenue $7B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

VLO

Valero

$98.69

-0.26 (-0.26%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Hot Stocks
Valero announces additional $2.5B share repurchase authorization »

The board of Valero…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

CMRE

Costamare

$6.16

-0.12 (-1.91%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Earnings
Costamare reports Q4 EPS 17c, consensus 15c »

On January 23, 2018,the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:22
01/23/18
01/23
16:22
01/23/18
16:22
Hot Stocks
Capital One reports Q4 net interest margin 7.03%, down 5 bps »

Reports Efficiency ratio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

VLO

Valero

$98.69

-0.26 (-0.26%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Hot Stocks
Valero increases dividend 14% »

The board of Valero…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

COF

Capital One

$105.71

0.22 (0.21%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Earnings
Capital One reports Q4 adjusted EPS $1.62, consensus $1.88 »

Reports Q4 revenue $7B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

UMPQ

Umpqua Holdings

$22.11

-0.18 (-0.81%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Earnings
Breaking Earnings news story on Umpqua Holdings »

Umpqua Holdings reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 13

    Mar

COF

Capital One

$105.71

0.22 (0.21%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Earnings
Capital One reports Q4 adjusted EPS $1.62, consensus $1.88 »

Reports Q4 revenue $7B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

MULE

MuleSoft

$25.08

-0.31 (-1.22%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Initiation
MuleSoft initiated  »

MuleSoft initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

SIGM

Sigma Designs

$7.00

0.025 (0.36%)

, SLAB

Silicon Labs

$99.80

1.15 (1.17%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Hot Stocks
Sigma Designs to sell Z-Wave business to Silicon Labs for $240M »

Sigma Designs (SIGM)…

SIGM

Sigma Designs

$7.00

0.025 (0.36%)

SLAB

Silicon Labs

$99.80

1.15 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

SCOR

comScore

$23.65

-0.1 (-0.42%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Periodicals
comScore working with Goldman on potential sale, Bloomberg reports »

comScore is working with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQC

Equity Commonwealth

$30.37

0.33 (1.10%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Hot Stocks
Equity Commonwealth to sell two properties for $670M »

Equity Commonwealth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

AUO

AU Optronics

$4.69

0.03 (0.64%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Upgrade
AU Optronics rating change  »

AU Optronics upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Options
Closing CBOE SPX and VIX Index summary for January 23rd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPL

LG Display

$15.59

1.33 (9.33%)

16:19
01/23/18
01/23
16:19
01/23/18
16:19
Upgrade
LG Display rating change  »

LG Display upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$250.29

22.71 (9.98%)

, TRV

Travelers

$146.26

6.91 (4.96%)

16:19
01/23/18
01/23
16:19
01/23/18
16:19
General news
On The Fly: Top stock stories for Tuesday »

The Dow and S&P 500…

NFLX

Netflix

$250.29

22.71 (9.98%)

TRV

Travelers

$146.26

6.91 (4.96%)

VZ

Verizon

$53.23

-0.23 (-0.43%)

JNJ

Johnson & Johnson

$141.83

-6.31 (-4.26%)

PG

Procter & Gamble

$89.05

-2.84 (-3.09%)

TSLA

Tesla

$352.79

1.23 (0.35%)

DIS

Disney

$110.41

-0.69 (-0.62%)

JPM

JPMorgan

$114.21

-0.12 (-0.10%)

RMD

ResMed

$100.35

12.84 (14.67%)

WHR

Whirlpool

$171.98

5.33 (3.20%)

INSM

Insmed

$29.01

-1.855 (-6.01%)

TWTR

Twitter

$22.75

-0.57 (-2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 30

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 16

    Feb

  • 27

    Feb

  • 28

    Feb

  • 08

    Mar

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

VMW

VMware

$137.96

1.27 (0.93%)

16:19
01/23/18
01/23
16:19
01/23/18
16:19
Initiation
VMware initiated  »

VMware initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.